Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.39 HKD | -3.94% | -13.41% | -36.28% |
May. 16 | InnoCare Pharma Announces the Completion of Patient Enrollment in the Phase II Clinical Trial of ICP-488 for the Treatment of Psoriasis | CI |
May. 14 | Innocare Pharma Posts Q1 Loss | MT |
Sales 2024 * | 887M 122M 956M | Sales 2025 * | 1.34B 185M 1.45B | Capitalization | 8.34B 1.15B 8.99B |
---|---|---|---|---|---|
Net income 2024 * | -725M -100M -782M | Net income 2025 * | -507M -69.99M -547M | EV / Sales 2024 * | -1.61 x |
Net cash position 2024 * | 9.77B 1.35B 10.53B | Net cash position 2025 * | 12.07B 1.67B 13.02B | EV / Sales 2025 * | -2.79 x |
P/E ratio 2024 * |
-9.53
x | P/E ratio 2025 * |
-15.3
x | Employees | 1,089 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 56.11% |
Latest transcript on InnoCare Pharma Limited
1 day | -3.94% | ||
1 week | -13.41% | ||
Current month | -5.18% | ||
1 month | -2.66% | ||
3 months | -15.41% | ||
6 months | -34.48% | ||
Current year | -36.28% |
Managers | Title | Age | Since |
---|---|---|---|
Jisong Cui
CEO | Chief Executive Officer | 62 | 15-11-02 |
Xin Fu
DFI | Director of Finance/CFO | 46 | Dec. 17 |
Kevin Gao
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yigong Shi
FOU | Founder | 57 | 15-11-02 |
Kai Xian Chen
BRD | Director/Board Member | 78 | 20-02-29 |
Jisong Cui
CEO | Chief Executive Officer | 62 | 15-11-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.14% | 4 M€ | -27.92% | ||
0.13% | 2 M€ | -14.14% | ||
0.01% | 112 M€ | +4.59% | - | |
0.00% | 45 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-26 | 4.39 | -3.94% | 1 473 000 |
24-05-24 | 4.57 | -3.18% | 4,466,000 |
24-05-23 | 4.72 | -4.45% | 1,904,000 |
24-05-22 | 4.94 | +1.44% | 2,171,000 |
24-05-21 | 4.87 | -3.94% | 2,562,000 |
Delayed Quote Hong Kong S.E., May 26, 2024 at 10:37 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.28% | 1.15B | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- 9969 Stock